BTMD
Biote Corp. Class A Common Stock
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Biote (BTMD) Stock: Buy, Sell, or Hold?
$1.03
-0.06 (-5.50%)
▼
5d:
-0.96%
30d:
-8.85%
90d:
-29.93%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
37/100
Position
OVERSOLD
30-Day Fair Range
$1.06 – $1.16
Position: OVERSOLD
Forward P/E & Valuation
3.0x
FAIR
vs 3.2x historical avg
Wall Street Target
$2.22
+115.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.99 / $1.24
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BTMD shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.12
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.32
21.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.03, which is considered oversold relative to its 30-day fair value range of $1.06 to $1.16. The stock's valuation (Forward PE: 3.0) is in line with its historical norms (3.2). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BTMD is in a strong downtrend. Immediate support is located at $0.99, while resistance sits at $1.24. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.22 (+115.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BTMD is in a strong downtrend. Immediate support is located at $0.99, while resistance sits at $1.24. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.22 (+115.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.06 -
$1.16
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.8%
Trading Range & Key Levels
30-Day Trading Range
$1.06 -
$1.16
Current vs Trading Range
OVERSOLD
Support Level
$0.99
Resistance Level
$1.24
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 115.9% below Wall St target ($2.22)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
3.03
Wall Street Target
$2.22
(+115.9%)
Revenue Growth (YoY)
-9.6%
Earnings Growth (YoY)
-95.5%
Profit Margin
-1.1%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
3.0 vs 3.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$1.02
(-1%)
2-Year Target
$1.00
(-3%)
3-Year Target
$0.99
(-4%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$1.04
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 30.8%)
$15.10
(+1366%)
Base:
(SPY PE: 3.0, Growth: 30.8%)
$2.30
(+124%)
Bear:
(PE: 2.6, Growth: 30.8%)
$1.96
(+90%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 8.79 | Current EPS (TTM): $0.14
Bull Case
$2.71
(+160%)
Analyst growth 100.0%, PE expands to 9.7
Base Case
$2.46
(+137%)
Market implied 100.0%, PE stable at 8.8
Bear Case
$0.84
(-20%)
Severe decline -20.0%, PE contracts to 7.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.0 to 3.2
Stabilization Target:
$1.09
(+5.6%)
PE Expansion Potential:
+5.6%
Share BTMD Analysis
Share this live BTMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BTMD)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 5, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows bullish sentiment for $BTMD with one user expressing excitement about the stock. No recent news articles are available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 39 SELL |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 31 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 45 HOLD |
|
PNTG
Pennant Group Inc |
STRONG BUY
7 analysts |
$48 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BTMD Research Pages
